In collaboration with The Barron Lab and Maxwell Biosciences, the Santa Maria Lab has received NIH funding through the National Institute for Deafness and Communication Disorders. The grant aims to translate antimicrobial peptoids for the treatment of chronic suppurative otitis media. This is the culmination of an ongoing collaboration between the Barron Lab, the inventors of the peptoids and the Santa Maria Lab who will look to show efficacy in their animal model and test for safety and toxicity.